Puneet Dhamija

6PUBLICATIONS
20CO-AUTHORS
Biomolecular modelling and designHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Information systems for sustainable development and the public goodMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 18, 2026
In Silico Analysis of Enantioselective Binding of Pomalidomide Targets for Multiple Myeloma.

|Dec 25, 2025
Upfront Combined Hydroxyurea and Imatinib versus Imatinib Monotherapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Randomized Controlled Trial.

Rituparna Chetia, Sarika Palepu, Vikramjeet Dutta

|Aug 29, 2023
Safety and efficacy of Vitamin D3 supplementation with Imatinib in Chronic Phase- Chronic Myeloid Leukaemia: an Exploratory Randomized Controlled Trial.

Arkapal Bandyopadhyay, Sarika Palepu, Puneet Dhamija

|Nov 27, 2021
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.

Jitendra Kumar Chaudhary, Rohitash Yadav, Pankaj Kumar Chaudhary

|Sep 28, 2021
Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets.

Jitendra Kumar Chaudhary, Rohitash Yadav, Pankaj Kumar Chaudhary

|Apr 30, 2021
Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.

Rohitash Yadav, Jitendra Kumar Chaudhary, Neeraj Jain

Pageof 1

Frequent Collaborators

3 joint publications

Rohitash Yadav

3 joint publications

Jitendra Kumar Chaudhary

3 joint publications

Neeraj Jain

2 joint publications

Ramasare Prasad